The association between smoking and long-term outcomes after non-ST-segment elevation myocardial infarction in older patients

American Heart Journal

Volumn 166, Issue 6, 2013, Pages 1056-1062

  Shen, Lan ^a,b   Peterson, Eric D ^b   Li, Shuang ^b   Thomas, Laine ^b   Alexander, Karen ^b   Xian, Ying ^b   Wang, Tracy Y ^b   Roe, Matthew T ^b   He, Ben ^a   Shah, Bimal R ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART INFARCTION; HEART RATE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVASCULARIZATION; SMOKING; ST SEGMENT DEPRESSION; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; AGE DISTRIBUTION; LONGITUDINAL STUDY; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MYOCARDIAL INFARCTION; PATIENT READMISSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RENAL INSUFFICIENCY, CHRONIC; SMOKING; UNITED STATES;

EID: 84888638271     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.09.011     Document Type: Article

References (22)

1. R. Doll, and R. Peto Mortality in relation to smoking. Twenty years' observations of male British doctors BMJ 215 1976 25 36
2. M. Ezzati, S.J. Henley, and M.J. Thun Role of smoking in global and regional cardiovascular mortality Circulation 112 2005 489 497
3. G.I. Barbash, J. Reiner, and H.D. White Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries J Am Coll Cardiol 26 1995 1222 1229
4. S.G. Gourlay, A.C. Rundle, and H.V. Barron Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infartion 2 (NRMI 2) Nicotine Tob Res 4 2002 101 107
5. D. Himbert, M. Klutman, G. Steg GRACE Investigators Cigarette smoking and acute coronary syndromes: a multinational observational study Int J Cardiol 100 2005 109 117
6. F. Kunz, C. Pechlaner, and H. Hörtnagl The smoker's paradox and the real risk of smoking Eur J Epidemiol 20 2005 161 167
7. G. Weisz, D.A. Cox, and E. Garcia Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited Am Heart J 150 2005 358 364
8. G.K. Andrikopoulos, D.J. Richter, and P.E. Dilaveris In-hospital mortality of habitual cigarette smokers after acute myocardial infarction Eur Heart J 22 2001 776 784
9. G.I. Barbash, H.D. White, M. Modan for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial Acute myocardial infarction in the young - the role of smoking Eur Heart J 16 1995 313 316
10. E. Aune, J. Roislien, and M. Mathisen The "smoker's paradox" in patients with acute coronary syndrome: a systematic review BMC Med 9 2011 97
11. I.J. Dahabrech, and D.M. Kent Index event bias as an explanation for the paradoxes of recurrent risk research JAMA 305 2011 822 823
12. J.W. Ryan, E.D. Peterson, and A.Y. Chen CRUSADE Investigators. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry Circulation 112 2005 3049 3057
13. B.G. Hammill, A.F. Hernandez, and E.D. Peterson Linking inpatient clinical registry data to Medicare claims data using indirect identifiers Am Heart J 157 2009 995 1000
14. J.D. Kalbfleisch, and R.L. Prentice The statistical analysis of failure time data 1980 John Wiley & Sons, Inc New York, NY
15. R.J. Gray A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
16. M.T. Roe, A.Y. Chen, and L. Thomas Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score Am Heart J 162 2011 875 883
17. G.I. Barbash, H.D. White, M. Modan for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial Circulation 87 1993 53 58
18. A.P. Maggioni, F. Piantadosi, and G. Tognoni Smoking is not a protective factor for patients with acute myocardial infarction: the viewpoint of the GISSI-2 Study G Ital Cardiol 28 1998 970 978
19. P. Mølstad First myocardial infarction in smokers Eur Heart J 12 1991 753 759
20. M. Ruiz-Bailén, E.A. de Hoyos, A. Reina-Toral ARIAM Group Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: results of the ARIAM Register Chest 125 2004 831 840
21. D.J. Moliterno, J.E. Willard, and R.A. Lange Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both N Engl J Med 330 1994 454 459
22. J.A. Critchley, and S. Capewell Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review JAMA 290 2003 86 97